Department of Health and Human Services October 29, 2009 – Federal Register Recent Federal Regulation Documents
Results 1 - 6 of 6
Investigational New Drug Applications; Technical Amendment
The Food and Drug Administration (FDA) is amending its investigational new drug application (IND) regulations to add an
Findings of Scientific Misconduct
Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case:
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.